Arcus Biosciences
RCUS
RCUS
200 hedge funds and large institutions have $1.09B invested in Arcus Biosciences in 2022 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 74 increasing their positions, 64 reducing their positions, and 23 closing their positions.
Holders
200
Holders Change
+16
Holders Change %
+8.7%
% of All Funds
3.23%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
41
Increased
74
Reduced
64
Closed
23
Calls
$6.61M
Puts
$14.7M
Net Calls
-$8.1M
Net Calls Change
-$7.52M
Top Buyers
| 1 |
WP
1
Woodline Partners
San Francisco,
California
|
$24.8M |
| 2 |
FAM
2
Fred Alger Management
New York
|
$13.5M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$13.3M |
| 4 |
4
T. Rowe Price Associates
Baltimore,
Maryland
|
$10.5M |
| 5 |
5
BlackRock
New York
|
$194M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
226
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
227
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
SFG
228
Steward Financial Group
Colleyville,
Texas
| $0 | 13 | +13 | New |
|